- 拝啓 時下益々ご清栄のこととお慶び申し上げます。平素は格別のご高配を賜り厚くお礼申し上げます。 さて、修理依頼品及び修理サービスに関しまして、2023年 9 月1 日 (金)よ り、各製品の修理費用が定額制となりますことをお知らせいたします。 何卒、ご理解を賜りますようお願い申し上げます。    今後もより一層のサービス向上に努めてまいりますので、引き続きご愛顧を賜りますようお願い申し上げます。 敬具 新修理体制フローチャート及び定価表はこちら


- 拝啓 時下ますますご清栄のこととお慶び申し上げます。平素は格別のご高配を賜り厚くお礼申し上げます。  さて、昨今の世界情勢並びに円安の影響により、原材料や運送費などのコストが上昇しております。弊社におきましても、本年1月1日に一部製品を値上げさせていただき、その他の製品価格は据え置きとしておりました。その後も、経費削減、生産効率化などを推進し価格維持に努めて参りましたが、現在の価格体系を維持することが困難な状況となりました。  つきましては、誠に不本意ながら 2023 年 9月 1 日 (金) より、製品および修理に関しまして全面的な価格改定をお願いしたく存じます。何卒事情をご賢察の上、ご理解ご協力賜りますようお願い申し上げます。 敬具 対象製品と新価格はこちら

Log4j security vulnerability - seca products are not affected.

- In connection with the latest findings about Log4J vulnerabilities, seca has conducted extensive analyses to ensure the security of our devices and thus the (data) security of our customers. The open source tool called Log4J is not used in any of our products. This means that none of our products are affected by the security vulnerabilities. In the development of our products we attach great importance to the highest security standards and will do our utmost to maintain them in the future, so that our partners can rely on us. If you have any further questions, please contact

COVID-19: Do not ignore basic parameters such as weight, height, and vital signs, especially in risk groups

- The COVID-19 pandemic poses major challenges to doctors and health systems worldwide. People with pre-existing health conditions have an even higher risk of experiencing a severe infection. Publications in medical journals and by independent organizations indicate that the exact measurement of vital parameters can play a major role in the treatment of risk groups with COVID-19. Height, weight, and vital signs such as blood pressure, oxygen saturation, pulse, and temperature are relevant for the exact dosage of medications and ventilator settings. In addition, this information helps with disease diagnosis and follow-up control measures.

seca increases production capacities for system-relevant medical technology

Supply of hospitals, emergency departments and medical practices has the highest priority

- In many countries, authorities and competent institutions have classified seca and its medical technology as system relevant to support health systems in the fight against the COVID 19 pandemic. Due to the current situation, the pressure in emergency rooms and hospitals is very high and the need for medical technology has continued to increase. The company is maintaining production and expanding capacities to best serve this demand and to contribute to the fight against the corona virus.

A strong partner – in the time of Covid-19 too

We stand by you

- While the whole world is attempting to slow down the number of new infections with coronavirus, we are concentrating on protecting our employees and instituting measures to make sure our production in Hamburg remains fully operational. Our production site in Hangzhou has returned to 90 percent of production capacity since China ended its shutdown. That gives us hope and sends a positive signal to everyone. We take this opportunity to thank all our employees and partners whose support and engagement are keeping our products and service available to all who need them.

seca is awarded MDR certification

EU Medical Device Regulation successfully implemented three months before it fully comes into force

- As one of the first Med Tech companies in Europe, seca is the global market leader in medical measuring and weighing and has passed the official MDR (Medical Device Regulation) audit even before the new EU regulation comes into effect in May 2020. Three auditors from the Notified Body (TÜV-SÜD Product Service) analyzed and audited the seca quality management system in accordance with the MDR requirements for medical devices and assessed all of them as successfully met.

Global medical societies define reduced muscle mass as an independent criterion for diagnosis of malnutrition

Validated BIA from seca conforms to consensus on diagnostic methods

- The international societies ASPEN, ESPEN, FELANPE and PENSA established the Global Leadership Initiative in Malnutrition (GLIM) to build a worldwide consensus for diagnostic criteria for malnutrition. The consensus report published in September 2018 elevates reduced muscle mass to one of the decisive, independent evaluation criteria used in the diagnosis of malnutrition. seca welcomes this step, which the company sees as validation of its advocacy of improved diagnosis and treatment of malnutrition.